Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Soft tissue sarcoma: What is best practice?

Connective Tissue Oncology Society (CTOS) 2016 Annual Meeting – Industry satellite symposium

Chaired by Alessandro Gronchi with Angelo Paolo Dei Tos, Peter Hohenberger, and Robin Jones

Held on Thursday 10th November 2016 at the Corinthia Hotel Lisbon

This symposium discussed the treatment of soft tissue sarcoma, focussing on the implementation of new discoveries within everyday clinical practice. The expert Faculty provide their insights into how to best utilize the latest evidence, especially within the context of the multidisciplinary care team.

Scientific summary

© Springer Healthcare IME

Faculty bios

Learning objectives

The aim of the symposium was to enable attendees to:

  • Describe the biological pathways involved in STS and discuss their implications for the pathology of STS
  • Assess the new treatment and diagnosis paradigms for advanced-STS and explain how to best apply them to their daily practice
  • Explain the current best practice for providing treatment for STS within the context of the multidisciplinary team

Educational grant

This programme was made possible thanks to independent educational sponsorship from Eli Lilly and Company.

Produced by Springer Healthcare IME.

Accreditation

New Content Item

The ‘Soft tissue sarcoma: what is best practice?’ is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

The ‘Soft tissue sarcoma: what is best practice?’ is designated for a maximum of (or ‘for up to’) 1 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Contact us

Email: IME@springer.com
Telephone +44 (0) 203 192 2023
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK